Background
Methods
Animals
Cell culture
Measurement of breast cancer primary tumor and pulmonary metastasis
Measurement of NO production in the lungs
Quantitative assessment of Snail expression in the pulmonary circulation
Measurement of pulmonary endothelium permeability by Evans blue
Western blot analysis
Measurement of platelet basal activity and ADP-induced reactivity
Statistical analysis
Results
Development of pulmonary metastasis and systemic inflammation in the orthotopic murine 4T1 breast cancer model
Parameter | Week after 4T1 cancer cell inoculation | |||||
---|---|---|---|---|---|---|
Control | 1st | 2nd | 3rd | 4th | 5th | |
Lung weight (g) | 0.76; 0.70–0.80 (n = 30) | 0.77; 0.70–0.81 (n = 29) | 0.76; 0.72–0.84 (n = 30) | 0.81; 0.76–0.85 (n = 29) | 0.0.82; 0.77–0.91 (n = 30) | 1.7; 1.3–2.22*** (n = 49) |
WBC (K/μl) | 4.20; 3.41–5.22 (n = 35) | 4.70; 4.04–5.28 (n = 21) | 5.55; 4.94–6.21 (n = 23) | 17.02; 11.85–24.78*** (n = 23) | 54.62; 96.18–177.10*** (n = 20) | 257.30; 148.20–317.10*** (n = 36) |
GRA (K/μl) | 1.00; 0.80–1.20 (n = 35) | 1.25; 1.10–1.40 (n = 21) | 1.85; 1.35–2.40* (n = 23) | 11.30; 6.95–16.10*** (n = 23) | 79.00; 42.48–132.80*** (n = 20) | 159.80; 89.25–220.90*** (n = 36) |
LYM (K/μl) | 3.10; 2.50–3.85 (n = 35) | 3.25; 2.75–3.87 (n = 21) | 3.40; 2.80–3.90 (n = 23) | 5.65; 4.15–7.00*** (n = 23) | 18.50; 9.75–24.13*** (n = 20) | 46.90; 25.00–95.00*** (n = 35) |
Spleen weight (g) | 0.10; 0.09–0.11 (n = 20) | 0.10; 0.09–0.11 (n = 30) | 0.12; 0.11–0.13 (n = 30) | 0.24; 0.20–0.32** (n = 30) | 0.54; 0.43–0.68*** (n = 30) | 0.89; 0.79–0.99*** (n = 70) |